Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection

被引:57
作者
Watanabe, H
Enomoto, N
Nagayama, K
Izumi, N
Marumo, F
Sato, C
Watanabe, M
机构
[1] Tokyo Med & Dent Univ, Fac Med, Dept Gastroenterol & Hepatol, Dept Internal Med 2,Bunkyo Ku, Tokyo 1138519, Japan
[2] Tokyo Med & Dent Univ, Fac Med, Dept Hlth Sci, Tokyo 1138519, Japan
[3] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
关键词
D O I
10.1086/319674
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To explore the relationship between responses to interferon (IFN) and the mutation patterns in the IFN sensitivity-determining region (ISDR; amino acid positions 2209-2248) in the NS5A gene of hepatitis C virus genotype 1b, a cohort of 334 patients was analyzed. The number of mutations in the ISDR was higher in patients with sustained response (SR) than in patients with transient or no response (P < .001). Patients with viruses mutated at positions 2209 (P = .02), 2216 (P = .01), or 2227 (P = .02) more frequently experienced SR than did those without these mutations. Mutation occurred most frequently at position 2218, where the presence of cysteine was significantly associated with SR. Thus, the mutation pattern in the ISDR affects the virologic response to IFN and reflects different influences on the function of the NS5A protein. ISDR sequence analysis would allow the prediction of clinical IFN efficacy in individual patients.
引用
收藏
页码:1195 / 1203
页数:9
相关论文
共 54 条
[1]   The direct interplay between HCVNS5A protein and interferon transduction signal: from clinical to basic science [J].
Brechot, C .
JOURNAL OF HEPATOLOGY, 1999, 30 (06) :1152-1154
[2]   Chronic hepatitis C:: Interferon retreatment of relapsers.: A meta-analysis of individual patient data [J].
Cammà, C ;
Giunta, M ;
Chemello, L ;
Alberti, A ;
Toyoda, H ;
Trepo, C ;
Marcellin, P ;
Zahm, F ;
Schalm, S ;
Craxi, A .
HEPATOLOGY, 1999, 30 (03) :801-807
[3]   The pattern of response to interferon alpha (α-IFN) predicts sustained response to a 6-month α-IFN and ribavirin retreatment for chronic hepatitis C [J].
Cavalletto, L ;
Chemello, L ;
Donada, C ;
Casarin, P ;
Belussi, F ;
Bernardinello, E ;
Marino, F ;
Pontisso, P ;
Gatta, A ;
Alberti, A .
JOURNAL OF HEPATOLOGY, 2000, 33 (01) :128-134
[4]   Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection [J].
Chayama, K ;
Tsubota, A ;
Kobayashi, M ;
Okamoto, K ;
Hashimoto, M ;
Miyano, Y ;
Koike, H ;
Kobayashi, M ;
Koida, I ;
Arase, Y ;
Saitoh, S ;
Suzuki, Y ;
Murashima, N ;
Ikeda, K ;
Kumada, H .
HEPATOLOGY, 1997, 25 (03) :745-749
[5]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[6]  
Chung RT, 1999, J MED VIROL, V58, P353, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt
[7]  
353::AID-JMV6&gt
[8]  
3.0.CO
[9]  
2-C
[10]   Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C [J].
Davis, GL ;
Esteban-Mur, R ;
Rustgi, V ;
Hoefs, J ;
Gordon, SC ;
Trepo, C ;
Shiffman, ML ;
Zeuzem, S ;
Craxi, A ;
Ling, MH ;
Albrecht, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1493-1499